EGFR MUTATION ANALYSIS BY PCR
therascreen® EGFR RGQ PCR - EGFR
The therascreen® EGFR RGQ PCR Kit enables the detection of 21 mutations in exons 18, 19, 20, and 21 of the EGFR oncogene against a background of wild type genomic DNA.
therascreen® EGFR RGQ PCR assay is intended to be used to select patients with NSCLC for whom GILOTRIF™ (afatinib), an EGFR tyrosine kinase inhibitor (TKI), is indicated.
Specimen Collection Requirements
Formalin fix (10 percent neutral buffered formalin) and paraffin embedded tissue. Protect from excessive heat. Transport tissue block or 5 unstained 5-10micron slides. Minimum 3 slides.
FFPE Block or 5 unstained 5-10micron slides
3 unstained 5-10micron slides
Specimens fixed/processed in alternative fixatives (alcohol, Prefer®),fresh, frozen or decalcified specimens.
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable
This is a real time PCR assay using the FDA-approved, Qiagen therascreen® in vitro diagnostics (IVD) kit to detect the 21 mutations in exons 18, 19, 20, and 21 of the EGFR oncogene against a background of wild type genomic DNA.
Thursday, January 5, 2017 03:41:46 AM
Client Services: 503-413-1234